Skip to content

Male Infertility and Assisted Reproductive Technologies Research Biobank

Male Infertility and Assisted Reproductive Technologies Research Biobank

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06880302
Acronym
MARK
Enrollment
1000
Registered
2025-03-17
Start date
2025-03-04
Completion date
2032-12-01
Last updated
2026-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility (IVF Patients), Male Infertility

Brief summary

The objective of this research is to build a biobank of biological male specimens used for diagnostics and treatment of infertility or assisted reproductive technologies (ART).

Detailed description

The objective of this research is to build a biobank of biological male specimens used for diagnostics and treatment of infertility or assisted reproductive technologies (ART). These specimens include testicular tissue, sperm, semen samples, donor sperm or discarded sperm preps. These samples were possibly utilized for diagnostic testing such as semen analyses or DNA fragmentation testing or for ART procedures such as intrauterine insemination (IUI) in-vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) and are no longer needed clinically. Rather than discarding those samples the men who provided them or the sperm recipient in the case of donor sperm may elect to donate them for future research purposes. These samples will be used for future research regarding male infertility and assisted reproductive technologies.

Interventions

None listed

Sponsors

Reproductive Medicine Associates of New Jersey
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Healthy volunteers
No

Inclusion criteria

* Males providing testicular tissue, sperm, semen samples, discarded sperm preps for IUI/IVF/ICSI or the sperm recipient for those utilizing donor sperm, for cryopreservation at the respective site(s) for either clinical use or preservation

Exclusion criteria

* Samples that are quarantined or in isolation dewars for infectious diseases

Design outcomes

Primary

MeasureTime frameDescription
Biobank5 yearsThe purpose of this study is to create a biobank of male biological specimens

Countries

United States

Contacts

CONTACTCaroline Zuckerman, RN BSN
clinicalresearchteam@ivirma.com9736562841
CONTACTChristine Whitehead, MS, BSN, RN
clinicalresearchteam@ivirma.com9736562841

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 3, 2026